Safety and preliminary efficacy data from a phase I study of an implantable low intensity pulsed ultrasound (LIPU) device for disrupting the blood-brain barrier (BBB) in patients treated by chemotherapy for recurrent glioblastoma (GBM).

Idbaïh, Ahmed; Canney, Michael; Desseaux, Carole; Vignot, Alexandre; Law-Ye, Bruno; Leclercq, Delphine; Belin, Lisa; Bissery, Anne; Ricke, Y. de; Sanson, Marc; Hoang-Xuân, Khê; Dehais, Caroline; Houillier, Caroline; Laigle‐Donadey, Florence; Delattre, Jean‐Yves

doi:10.1200/jco.2018.36.15_suppl.2016

JCO

2018

DOI: 10.1200/jco.2018.36.15_suppl.2016

|View full text |Cite

Safety and preliminary efficacy data from a phase I study of an implantable low intensity pulsed ultrasound (LIPU) device for disrupting the blood-brain barrier (BBB) in patients treated by chemotherapy for recurrent glioblastoma (GBM).

Ahmed Idbaïh

Michael Canney²,

Carole Desseaux³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Safety and preliminary efficacy data from a phase I study of an implantable low intensity pulsed ultrasound (LIPU) device for disrupting the blood-brain barrier (BBB) in patients treated by chemotherapy for recurrent glioblastoma (GBM).

Cited by 1 publication

References 0 publications

Frontiers in the treatment of glioblastoma: Past, present and emerging

Frontiers in the treatment of glioblastoma: Past, present and emerging

Contact Info

Product

Resources

About